Jext® Adrenaline Auto-Injector (AAI)
Jext®
A complete overview of Jext® can be found in the Summary of Product Characteristics (SmPC) which can be viewed below. Patient resources and the Prescribing Information (PI) and Adverse Event reporting can also be found on the links below.

Jext® is a pre-filled adrenaline auto-injector designed for rapid intramuscular administration in cases of severe allergic reactions or anaphylaxis.
Jext is indicated in the emergency treatment of severe acute allergic reactions (anaphylaxis) to1:
- Insect stings or bites
- Foods, drugs and other allergens
- Idiopathic or exercise induced anaphylaxis.
Dosage:
Jext® 150 micrograms: For children 15–30 kg.1
Jext® 300 micrograms: For adults and children >30 kg.1
How to use Jext®
Jext® should be administered into the anterolateral thigh. The injection is delivered immediately after the black needle shield of the autoinjector is pressed firmly against the skin or other surface.1
Contraindications and special warnings
There are no absolute contraindications to the use of Jext® during an allergic emergency.1
Jext® should only be used after removing the yellow cap and is designed for intramuscular injection into the anterolateral thigh. Patients and carers must be educated to seek emergency medical help immediately after use, as symptoms may recur. Asthma increases risk of severe reaction, and special caution is advised in patients with cardiovascular, metabolic, or endocrine disorders. Sodium metabisulphite in Jext® can cause hypersensitivity in susceptible individuals, particularly those with asthma. Immobilise the leg during injection to reduce injury risk and instruct all close associates on proper administration technique.1
For full details consult the Jext® SmPC 150ug , SmPC 300ug and for patient training resources visit: Resources – Patients Jext
October 2026
GB-JXT-2600003
- Jext® 150ug Summary of Product Characteristics April 2025
